QR code

A favorable outcome of intensive immunotherapies for new-onset refractory status epilepticus (NORSE)

Abstract Background New-onset refractory status epilepticus (NORSE) is a newly defined critical disease entity characterized by prolonged periods of refractory epileptic seizure with no readily identifiable cause in otherwise healthy individuals. Its etiology is uncertain, but autoimmune encephaliti...

Volledige beschrijving

Bewaard in:
Hoofdauteurs: Satoshi Kodama, Noritoshi Arai, Akiyoshi Hagiwara, Akio Kimura, Sousuke Takeuchi
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BMC 2018-07-01
Reeks:Journal of Intensive Care
Onderwerpen:
Status epilepticus
New-onset refractory status epilepticus (NORSE)
Immunotherapy
Autoimmune encephalitis
Plasma exchange (PE)
Intravenous immunoglobulin (IVIG)
Online toegang:http://link.springer.com/article/10.1186/s40560-018-0315-7
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items